SUZY SCHMELTZ: Open Payments
NPI 1265658777 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$850 in 35 payments from 14 companies in 2025. Trend: 2023 $302 · 2024 $411 · 2025 $850
Food & beverage: $850
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $163 |
| ABBVIE INC. | 5 | $112 |
| UCB, Inc. | 4 | $111 |
| Regeneron Healthcare Solutions, Inc. | 4 | $111 |
| GENZYME CORPORATION | 2 | $68 |
| LEO Pharma Inc. | 3 | $59 |
| Galderma Laboratories, L.P. | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| Janssen Biotech, Inc. | 1 | $30 |
Products named: DUPIXENT, ILUMYA, Bimzelx, SKYRIZI, NEMLUVIO, Sotyktu, ADBRY, COSENTYX.
Industry payments across FL — which companies pay providers there.
